Advertisement
Loading...

Healwell AI Inc.

HWAIFPNK
Healthcare
Medical - Care Facilities
$0.65
$-0.01(-1.07%)
U.S. Market opens in 43h 43m
Advertisement

Healwell AI Inc. Fundamental Analysis

Healwell AI Inc. (HWAIF) shows weak financial fundamentals with a PE ratio of -6.63, profit margin of -29.43%, and ROE of -31.80%. The company generates $0.1B in annual revenue with weak year-over-year growth of 1.66%.

Key Strengths

Cash Position11.39%
PEG Ratio-0.22

Areas of Concern

ROE-31.80%
Operating Margin-19.16%
Current Ratio0.89
We analyze HWAIF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -16.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-16.6/100

We analyze HWAIF's fundamental strength across five key dimensions:

Efficiency Score

Weak

HWAIF struggles to generate sufficient returns from assets.

ROA > 10%
-14.38%

Valuation Score

Excellent

HWAIF trades at attractive valuation levels.

PE < 25
-6.63
PEG Ratio < 2
-0.22

Growth Score

Weak

HWAIF faces weak or negative growth trends.

Revenue Growth > 5%
1.66%
EPS Growth > 10%
0.00%

Financial Health Score

Moderate

HWAIF shows balanced financial health with some risks.

Debt/Equity < 1
0.71
Current Ratio > 1
0.89

Profitability Score

Weak

HWAIF struggles to sustain strong margins.

ROE > 15%
-3179.77%
Net Margin ≥ 15%
-29.43%
Positive Free Cash Flow
No

Key Financial Metrics

Is HWAIF Expensive or Cheap?

P/E Ratio

HWAIF trades at -6.63 times earnings. This suggests potential undervaluation.

-6.63

PEG Ratio

When adjusting for growth, HWAIF's PEG of -0.22 indicates potential undervaluation.

-0.22

Price to Book

The market values Healwell AI Inc. at 2.18 times its book value. This may indicate undervaluation.

2.18

EV/EBITDA

Enterprise value stands at -44.90 times EBITDA. This is generally considered low.

-44.90

How Well Does HWAIF Make Money?

Net Profit Margin

For every $100 in sales, Healwell AI Inc. keeps $-29.43 as profit after all expenses.

-29.43%

Operating Margin

Core operations generate -19.16 in profit for every $100 in revenue, before interest and taxes.

-19.16%

ROE

Management delivers $-31.80 in profit for every $100 of shareholder equity.

-31.80%

ROA

Healwell AI Inc. generates $-14.38 in profit for every $100 in assets, demonstrating efficient asset deployment.

-14.38%

Following the Money - Real Cash Generation

Operating Cash Flow

Healwell AI Inc. generates limited operating cash flow of $-10.48M, signaling weaker underlying cash strength.

$-10.48M

Free Cash Flow

Healwell AI Inc. generates weak or negative free cash flow of $-13.31M, restricting financial flexibility.

$-13.31M

FCF Per Share

Each share generates $-0.05 in free cash annually.

$-0.05

FCF Yield

HWAIF converts -4.96% of its market value into free cash.

-4.96%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.63

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.22

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.18

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.96

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.71

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.89

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.32

vs 25 benchmark

ROA

Return on assets percentage

-0.14

vs 25 benchmark

ROCE

Return on capital employed

-0.12

vs 25 benchmark

How HWAIF Stacks Against Its Sector Peers

MetricHWAIF ValueSector AveragePerformance
P/E Ratio-6.6329.38 Better (Cheaper)
ROE-31.80%739.00% Weak
Net Margin-29.43%-53619.00% (disorted) Weak
Debt/Equity0.710.39 Weak (High Leverage)
Current Ratio0.894.03 Weak Liquidity
ROA-14.38%-20116.00% (disorted) Weak

HWAIF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Healwell AI Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-11.93%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-1392.87%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-250.54%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ